Global COPD Drugs Market Forecast to 2023 COPD Market Report | Page 16

List of Figures
Figure No.
Figure Title
Page No.
Figure 81: Canada COPD Drugs Market, By Drug Type, By Value, 2013-2017 (USD Million) 90
Figure 82: Europe COPD Drugs Market, By Value, 2013-2017 (USD Million) 92
Figure 83: Europe Health Expenditure, By Select Country, 2016 (% of GDP) 94
Figure 84: Europe Population ages 65 years and above (% of total population), 2013-17 94
Figure 85: European Union, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2012-2016 95
Figure 86: European Union, Smoking Prevalence, Age 15+, 2012-2016 95
Figure 87: Cause of Death, EU-28, 2015, Per 1000000 inhabitants, Both Sex 96
Figure 88: Europe, COPD Prevalence, By Selected Countries, 2017, (In Million) 96
Figure 89: Mean Average Age At Which Majority of Population Affected By COPD, By Region 96
Figure 90: Europe COPD Drugs Market, By Value, 2018-2023 (USD Million) 97
Figure 91: Europe COPD Drugs Market Size, By Drug Type, 2017 (%) 98
Figure 92: Europe COPD Drugs Market Size, By Drug Type, 2023F (%) 98
Figure 93: Europe COPD Drugs Market, By Drug Type, By Value, 2013-2017 (USD Million) Figure 94: Europe COPD Drugs Market Size, By Countries, 2017 (%) 101
Figure 95: Europe COPD Drugs Market Size, By Countries, 2023F (%) 101
Figure 96: Germany COPD Drugs Market, By Value, 2013-2017 (USD Million) 103
Figure 97: Germany COPD Drugs Market, By Value, 2018-2023(USD Million) 103
Figure 98: Germany COPD Prevalence, 2013-2017, 2018E-20123E, (in Millions) 104
Figure 99: PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2012-2016 105
Germany, Population ages 65 and above, 2012-2017 (% total) 105
Figure 100:
(c) AZOTH Analytics
99
16